Neuroendocrine tumors (NETs) are a rare and diverse group of tumors that develop from neuroendocrine cells, which have both nerve-like and hormone-producing characteristics. Due to advancements in diagnosis and treatment, the medical and research communities are increasingly focusing on NETs. The Neuroendocrine Tumors Treatment Market has witnes